Short Description CPA facilitates collaborative research on optimal use of anti-infective drugs as a means to combat antimicrobial resistance. The research projects under CPA will help fill important gaps in knowledge about locally-relevant, real-world hospital practice and ways in which scientific training on appropriate drug use may assist healthcare professionals…
GHPP CPA supports efforts of African researchers and clinicians in the prudent use of antimicrobial drugs in low- and middle- income countries (LMICs). These countries have the highest rates of antimicrobial resistance (AMR) driven by high rates of antimicrobial utilisation. Pharmacogenomics (PGx) and Precision Medicine are emerging approaches to combat…
At the end of the first phase of the GHPP-DQA project, alumni and trainers from all DQA trainings as well as project staff from BfArM, InphA and WHO met for a virtual alumni meeting. The central point was a review of the activities and achievements of the DQA project so…
After being welcomed warmly by the management and entire staff of the chemistry division, the DQA team was introduced to the structures, the statuses as well as the perspectives of the laboratories at MCAZ. With three laboratory sections, the authority is able to perform the quality control of both medicines…
The meeting of the GHPP CPA project partners took place at the African Institute of Biomedical Science and Technology (AiBST). After an introduction by the founder and director of AiBST, Prof. Collen Masimirembwa, on the current situation of pharmacogenomics in Africa and already existing global scientific collaborations, the BfArM and…
Due to current COVID-19 related travel restrictions, the kickoff workshop of the PharmTrain-CoronaGlobal (PT-CoronaGlobal) project took place as an online event from 27 September to 29 September 2021. In collaboration with the Southern African Development Community (SADC) and the African Union Development Agency (AUDA-NEPAD), the project aims to strengthen the…